Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Open-market sale Director sold 6,571 shares at $205.45 ($1,350,012)
  3. 4 Open-market sale Director sold 4,179 shares at $205.45 ($858,576)
  4. 4 Derivatives Options or other derivatives
  5. SCHEDULE 13D/A Stake Beneficial Ownership Report
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Planned sale Director sold 467 shares at an average $191.05 ($89,219)
  11. 144 Insider Sale of Securities
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 4 Planned sale Director sold 467 shares at an average $179.44 ($83,800)
  14. 144 Insider Sale of Securities
  15. 4 Open-market sale Director sold 10,000 shares at an average $170.81 ($1,708,088)
  16. 4 Shares withheld for taxes Director gave up 115 shares (to pay taxes)
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 8-K Event Material agreement · New debt or obligation
  20. 4 Planned sale Director sold 467 shares at an average $162.26 ($75,775)

Page 7 of 115 · 2,300 filings